This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gomes, J. A. Articles by Chao, S. Search for Related Content PubMed PubMed Citation Articles by Gomes, J. A. Articles by Chao, S.

Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: a randomized, double-blind, placebo-controlled study

J. Anthony Gomes, MD, FACC^a, John Ip, MD, FACC^*, Francesco Santoni-Rugiu, MD^a, Davendra Mehta, MD, PhD, FACC^a, Arisan Ergin, MD^a, Steven Lansman, MD^a, Elena Pe, RN, NP^a, Teri Takle Newhouse, MS and Sally Chao, BS^a

^a Electrophysiology and Electrocardiography Section, the Zena and Michael Wiener Cardiovascular Institute, Department of Medicine, The Mount Sinai School of Medicine and the Mount Sinai Medical Center, New York, New York, USA
^* Thoracic Cardiovascular Institute, Lansing, Michigan, USA
Biostatistics Department, Medronic, Minneapolis, Minnesota, USA

View larger version (10K): [in a new window]   Figure 1 Kaplan-Meier analysis of the percentage of patients free of atrial fibrillation on sotalol as compared to placebo. The abscissa plots the time in days, and the ordinate plots the percentage of patients free of AF.